Perrigo Api Ltd, based in India, is a pharmaceutical company.
One of their notable products is FEXOFENADINE HYDROCHLORIDE, with a corresponding US DMF Number 29445.
Remarkably, this DMF maintains an Active status since its submission on October 29, 2015, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of May 24, 2016, and payment made on June 19, 2015, indicating their dedication to facilitating drug approvals, Categorized as Type II